Caribou Biosciences Inc. (CRBU)
NASDAQ: CRBU
· Real-Time Price · USD
1.97
-0.03 (-1.50%)
At close: Aug 15, 2025, 3:59 PM
1.98
0.51%
After-hours: Aug 15, 2025, 05:38 PM EDT
Caribou Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 6.45M | 9.92M | 9.99M | 11.47M | 33.11M | 33.4M | 34.48M | 34.61M | 14.25M | 14.69M | 13.85M | 12.72M | 13.39M | 10.68M | 9.6M | 8.02M | 5.24M | 12.25M |
Cost of Revenue | 2.36M | 3.22M | 3.93M | 4.72M | 2.86M | 3.13M | 3.52M | 2.45M | 4.21M | 3.94M | 3.64M | 3.01M | 17.77M | 29.24M | 38.6M | 50.35M | 40.7M | 35.95M |
Gross Profit | 5.27M | 7.88M | 7.24M | 7.93M | 30.25M | 30.27M | 30.95M | 32.16M | 10.05M | 10.75M | 10.21M | 9.71M | -4.38M | -18.57M | -29M | -42.33M | -35.45M | -23.7M |
Operating Income | -167.6M | -163.53M | -166.62M | -165.18M | -141.58M | -130.94M | -116.06M | -109.19M | -121.1M | -116.66M | -106.4M | -96.23M | -88.31M | -75.84M | -68.16M | -62.97M | -52.58M | -38.87M |
Interest Income | n/a | n/a | n/a | 46K | 4.82M | 7.87M | 10.7M | 10.65M | 7.35M | 4.3M | 1.47M | 1.54M | 98K | 144K | 148K | 151K | 133K | 98K |
Pretax Income | -164.27M | -147.87M | -149.11M | -147.93M | -123.25M | -115.07M | -101.88M | -94.48M | -111.13M | -108.31M | -99.35M | -90.59M | -84.92M | -72.53M | -66.6M | -63.5M | -50.67M | -38.28M |
Net Income | -164.26M | -147.86M | -149.1M | -148.12M | -123.44M | -115.26M | -99.01M | -91.5M | -108.25M | -103.7M | -96.03M | -87.52M | -81.74M | -71.09M | -66.92M | -63.15M | -50.11M | -37.67M |
Selling & General & Admin | 40.47M | 40.69M | 45.6M | 42.86M | 42.73M | 42.22M | 36.49M | 37.27M | 37.41M | 37.34M | 38.02M | 37.34M | 34.25M | 29.32M | 24.32M | 20.64M | 17.13M | 15.17M |
Research & Development | 124.11M | 131.9M | 130.15M | 130.97M | 129.13M | 120.15M | 112.08M | 106.53M | 97.94M | 94.02M | 82.23M | 71.61M | 67.45M | 57.2M | 53.44M | 50.35M | 40.7M | 35.95M |
Other Expenses | 10.97M | -1.18M | -1.89M | -710K | -2.82M | 511K | 4.31M | 8.03M | 9.99M | 8.41M | 7.18M | 5.63M | 3.39M | 1.67M | -167K | -2.25M | 210K | 512K |
Operating Expenses | 175.54M | 171.41M | 173.86M | 173.12M | 169.04M | 159.56M | 146.46M | 141.7M | 135.35M | 131.35M | 120.25M | 108.94M | 101.7M | 86.51M | 77.76M | 70.99M | 57.83M | 51.12M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16K | 104K | 104K | 104K | 90K | 7K | 13K | 19K | 22K |
Selling & Marketing Expenses | n/a | -856K | -856K | -2.83M | -2.83M | -1.97M | -1.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 126.48M | 173.44M | 176.61M | 176.66M | 174.69M | 164.35M | 150.54M | 143.81M | 135.35M | 131.35M | 120.25M | 108.94M | 101.7M | 86.51M | 77.76M | 70.99M | 57.83M | 51.12M |
Income Tax Expense | -9K | -9K | -9K | 193K | 193K | 193K | -2.86M | -2.99M | -2.88M | -4.61M | -3.32M | -3.07M | -3.18M | -1.42M | 370K | -305K | -518K | -595K |
Shares Outstanding (Basic) | 93.03M | 92.68M | 90.32M | 90.46M | 90.34M | 89.3M | 88.43M | 83.78M | 61.42M | 61.19M | 61M | 60.89M | 60.76M | 60.55M | 60.18M | 45.89M | 54.71M | 27.66M |
Shares Outstanding (Diluted) | 93.03M | 92.68M | 90.32M | 90.46M | 90.34M | 89.3M | 88.43M | 83.78M | 61.42M | 61.19M | 61M | 60.89M | 60.76M | 60.55M | 60.18M | 45.89M | 54.71M | 27.66M |
EPS (Basic) | -1.78 | -1.62 | -1.65 | -1.65 | -1.39 | -1.45 | -1.4 | -1.45 | -1.77 | -1.7 | -1.58 | -1.45 | -1.47 | -1.32 | -1.51 | -1.73 | -1.56 | -1.37 |
EPS (Diluted) | -1.78 | -1.62 | -1.65 | -1.65 | -1.39 | -1.45 | -1.4 | -1.45 | -1.77 | -1.7 | -1.58 | -1.45 | -1.47 | -1.32 | -1.51 | -1.73 | -1.56 | -1.37 |
EBITDA | -162M | -157.06M | -160.61M | -162.88M | -137.69M | -127.3M | -112.53M | -108.48M | -121.51M | -117.33M | -107.35M | -92.59M | -84.86M | -72.52M | -64.93M | -61.88M | -51.43M | -37.39M |
EBIT | -116.77M | -160.27M | -163.36M | -165.18M | -141.58M | -130.94M | -116.06M | -109.19M | -121.1M | -116.66M | -106.4M | -93.98M | -86.06M | -73.59M | -65.91M | -62.81M | -52.33M | -38.28M |
Depreciation & Amortization | 3.53M | 4.38M | 3.93M | 3.48M | 3.88M | 4.16M | 4.55M | 4.71M | 4.21M | 3.94M | 3.64M | 3.01M | 2.2M | 1.57M | 984K | 931K | 897K | 895K |